Lila Sciences - About the company
Lila Sciences is a series A company based in Cambridge (United States), founded in 2023 by Noubar Afeyan, Geoffrey von, Alexandra Sneider, Geoffrey Maltzahn and Ben Kompa. It operates as a Developer of AI-powered autonomous scientific research platforms. Lila Sciences has raised $552M in funding from investors like Flagship Pioneering, Collective Global and Braidwell, with a current valuation of $1.2B. The company has 163 active competitors, including 48 funded and 5 that have exited. Its top competitors include companies like OpenAI, Mistral AI and Anthropic.
Sectors and market segments that Lila Sciences operate in
Lila Sciences serves in the HealthTech, Life Sciences, High Tech, Native AI market segments.The primary business model of Lila Sciences are:Company Details
Developer of AI-powered autonomous scientific research platforms. These platforms integrate AI models with autonomous laboratory systems to design, conduct, and analyze scientific experiments across life, chemical, and materials sciences. The goal is to accelerate scientific discovery and address significant challenges by significantly increasing the speed, scale, and accuracy of research beyond human capabilities alone. This approach aims to reinvent the scientific method through the application of artificial intelligence.
- Website
- www.lila.ai/
- Email ID
- *****@lila.ai
Key Metrics
Founded Year
2023
Location
Cambridge, United States
Stage
Series A
Total Funding
$552M in 4 rounds
Latest Funding Round
Post Money Valuation
$1.2B as on Dec 31, 2025
Investors
Ranked
12th among 163 active competitors
Employee Count
552 as on Sep 30, 2026
Sign up to download Lila Sciences' company profile
Lila Sciences's funding and investors
Lila Sciences has raised a total funding of $552M over 4 rounds. Its first funding round was on Mar 06, 2025. Lila Sciences has 18 institutional investors.
Here is the list of recent funding rounds of Lila Sciences:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 30, 2026 | $2M | Series A | - | - | - | - |
Oct 14, 2025 | $115M | Series A | $1.3B | - | - | |
Sep 14, 2025 | $235M | Series A | $1B | - |
View details of Lila Sciences's funding rounds and investors
Lila Sciences' founders and board of directors
Founder? Claim ProfileThe founders of Lila Sciences are Noubar Afeyan, Geoffrey von, Alexandra Sneider, Geoffrey Maltzahn and Ben Kompa. Geoffrey Maltzahn is the CEO of Lila Sciences.
Here are the details of Lila Sciences' key team members:
- Noubar Afeyan: Co-Founder of Lila Sciences.
- Geoffrey von: Co-Founder & CEO of Lila Sciences.
- Alexandra Sneider: Co-Founder & Head of Corporate Development of Lila Sciences. Contact Info: 1 email address
- Geoffrey Maltzahn: Co-Founder & CEO of Lila Sciences and founder of 7 other companies, including Quotient, Tessera Therapeutics and Indigo. Contact Info: 1 email address
- Ben Kompa: Co-Founder & Head of AI Lab Innovation of Lila Sciences. Contact Info: 1 email address
View details of Lila Sciences's Founder profiles and Board Members
Lila Sciences' employee count trend
Lila Sciences has 552 employees as of Sep 26. Here is Lila Sciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Lila Sciences's Competitors and alternates
Top competitors of Lila Sciences include OpenAI, Mistral AI and Anthropic. Here is the list of Top 10 competitors of Lila Sciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | OpenAI 2015, San Francisco (United States), Series F | Artificial intelligence research and development platform offering advanced language models | $180B | 89/100 | |
2nd | Mistral AI 2023, Paris (France), Series C | Provider of customizable, open-source artificial intelligence models and solutions for various applications | $3.05B | 83/100 | |
3rd | Anthropic 2021, San Francisco (United States), Series H | Provider of AI safety and research company | $132B | 83/100 | |
4th | Developer of enterprise AI platform and multilingual language and retrieval models | $1.54B | 78/100 | ||
5th | Provider of AI research laboratory services | $379M | 71/100 | ||
6th | Provider of AI cloud infrastructure, foundational models, and applications | $74.9M | 68/100 | ||
7th | Open source based AI assistant for enterprises | $4.4B | 67/100 | ||
8th | AI powered code generation tool for developers | $1.4B | 67/100 | ||
9th | Aleph Alpha 2019, Heidelberg (Germany), Acquired | Provider of an AI-enabled text and image analytics platform | $533M | 66/100 | |
10th | Platform offering AI focused writing and reading assistants | $636M | 66/100 | ||
12th | Lila Sciences 2023, Cambridge (United States), Series A | Developer of AI-powered autonomous scientific research platforms | $552M | 65/100 |
Looking for more details on Lila Sciences's competitors? Click here to see the top ones
Lila Sciences's Investments and acquisitions
Lila Sciences has made no investments or acquisitions yet.
Reports related to Lila Sciences
Here is the latest report on Lila Sciences:
News related to Lila Sciences
Media has covered Lila Sciences for a total of 9 events in the last 1 year.
•
Lila Sciences Raises $350M in Series A FundingFinSMEs•Jun 04, 2026•Lila Sciences, Braidwell, Catalio Capital Management
•
Lila Sciences is testing how much investors will pay for automated labsStartup Fortune•Jun 03, 2026•Lila Sciences
•
Lila Sciences Discusses Attracting $2 Billion Investment at $8.5 Billion ValueInvesting•Jun 03, 2026•Lila Sciences
•
AI Healthcare & Biotech Startups See Record Funding in 2025Techloy•Nov 19, 2025•Lila Sciences, OpenEvidence, Isomorphic Labs, Abridge Inc
•
Expedition Medicines launches to make small molecules with AI, led by former Lila Sciences and Generate execEndpoints•Oct 22, 2025•Lila Sciences, Generate Biomedicines, BioPharmaDive, Expedition Medicines
•
AI startup Lila Sciences receives $115 million in new funding from NVIDIAPANews•Oct 14, 2025•Lila Sciences, Nvidia, Moderna
•
Lila Sciences closes $350M Series A for its AI-driven science visionEndpoints•Oct 14, 2025•Lila Sciences, Braidwell, NVentures, Analog Devices and 10 others
•
US AI biotech startup Lila Sciences raises $235m, valued at $1.2bTech in Asia•Sep 15, 2025•Lila Sciences, Collective Global, Braidwell, Modi Ventures and 1 other
•
Lila Sciences nears $300M+ fundraise at $1B+ valuation to scale AIEndpoints•Sep 13, 2025•Lila Sciences
•
Lila Sciences raises $200M to accelerate autonomous scientific researchSiliconAngle•Mar 11, 2025•Lila Sciences, General Catalyst, March Capital, Ark Invest ETFs and 3 others
Are you a Founder ?
FAQs about Lila Sciences
Explore our recently published companies
- Nettech Bilisim ve Siber Guvenlik A.S - Turkey based, 2001 founded, Unfunded company
- Reef - Hamburg based, 2026 founded, Unfunded company
- Armand Vasseghi - Unfunded company
- Fesci Contract - 1997 founded, Unfunded company
- UTG - Singapore based, Unfunded company
- Blank Space - Unfunded company